Growth Metrics

Calumet (CLMT) EBITDA Margin (2023 - 2025)

Historic EBITDA Margin for Calumet (CLMT) over the last 3 years, with Q3 2025 value amounting to 29.95%.

  • Calumet's EBITDA Margin rose 351400.0% to 29.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.84%, marking a year-over-year increase of 55200.0%. This contributed to the annual value of 0.19% for FY2024, which is 62000.0% down from last year.
  • Calumet's EBITDA Margin amounted to 29.95% in Q3 2025, which was up 351400.0% from 9.84% recorded in Q2 2025.
  • In the past 5 years, Calumet's EBITDA Margin ranged from a high of 29.95% in Q3 2025 and a low of 9.84% during Q2 2025
  • Moreover, its 3-year median value for EBITDA Margin was 1.47% (2024), whereas its average is 3.61%.
  • As far as peak fluctuations go, Calumet's EBITDA Margin plummeted by -237200bps in 2024, and later skyrocketed by 351400bps in 2025.
  • Quarter analysis of 3 years shows Calumet's EBITDA Margin stood at 1.42% in 2023, then skyrocketed by 268bps to 2.39% in 2024, then surged by 1153bps to 29.95% in 2025.
  • Its EBITDA Margin was 29.95% in Q3 2025, compared to 9.84% in Q2 2025 and 4.9% in Q1 2025.